EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression

Paul J Hoover, Thomas M Eisenhaure, Jeffrey Hodgin, William Apruzzese, Joseph Mears, Michael Peters, Tony Jones, Sujal I Shah, Haniya Kamal, Rollin Leavitt, Shaun W Jackson, Patrick Danaher und 36 weitere

Annals of the Rheumatic Diseases · 2026-07 · 85 (7) · 1324-1340

DOI: 10.1016/j.ard.2026.03.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026-07. Verfasst von Paul J Hoover und 47 weiteren Autor:innen. Beteiligte Einrichtung: Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigh…. Hauptthemen laut MEDLINE: Lupus Nephritis, Myeloid Cells, Kidney. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, NIAID NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Lupus nephritis (LN) is a common, potentially fatal manifestation of systemic lupus erythematosus. We aimed to gain new insights into the immune responses underlying LN and their relation to the histologic heterogeneity observed in this disease, focusing on myeloid cells. METHODS: We used single-cell RNA-sequencing (scRNA-seq) data of dissociated kidney samples from 156 patients with LN and 30 healthy individuals. We applied spatial transcriptomics (ST), utilising a gene panel designed to capture all myeloid subsets identified in the scRNA-seq data, to profile kidney samples acquired from 6 patients with LN and 2 controls. RESULTS: We generated a catalogue of the myeloid subsets found in LN kidneys. Our analyses indicated that an increase in irreversible tissue damage, as measured by the National Institutes of Health chronicity index (CI), is associated with a gradual switch of the local immune response from one dominated by monocytes and macrophages to one featuring expanded CD4 T, GZMK+ CD8 T, B, and dendritic cells, with a parallel decrease in the interferon response. In proliferative/mixed LN only, the degree of active inflammation correlates with the expansion of disease-specific macrophage (DMac) subsets, which later contract as the CI increases. Trajectory analysis of the scRNA-seq data suggested that DMacs arise from both infiltrating monocytes and tissue-resident macrophages; this was supported by the ST data, as well as cell cultures. DMacs are implied to interact with parietal epithelial cells, promoting the development of glomerulosclerosis. CONCLUSIONS: We suggest a detailed picture of the changes in the kidney immune mechanisms in LN as this disease progresses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisMyeloid CellsKidneyHumansDisease ProgressionFemaleDendritic CellsMacrophagesAdultMaleCase-Control StudiesSingle-Cell AnalysisGene Expression ProfilingSpatial TranscriptomicsSingle-Cell Gene Expression AnalysisCD8-Positive T-Lymphocytes

Autor:innen und Institutionen

  • Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts…
  • Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
  • Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA; Seattle Children's Research Institute, Seattle, Washington, USA.

Förderung

  • NIAMS NIH HHS
  • NIAID NIH HHS
  • NIDDK NIH HHS
  • National Institutes of Health

Zitieren

APA

Hoover, P. J., Eisenhaure, T. M., Hodgin, J., Apruzzese, W., Mears, J., Peters, M., Jones, T., Shah, S. I., Kamal, H., Leavitt, R., Jackson, S. W., Danaher, P., Rao, D. A., Xiao, Q., Gurajala, S., Ai, J., Fava, A., Berthier, C. C., Horisberger, A., …, & Arazi, A. (2026). Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression. Annals of the Rheumatic Diseases, 85(7), 1324-1340. https://doi.org/10.1016/j.ard.2026.03.004

Vancouver

Hoover PJ, Eisenhaure TM, Hodgin J, Apruzzese W, Mears J, Peters M, et al. Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression. Annals of the Rheumatic Diseases. 2026;85(7):1324-1340. doi:10.1016/j.ard.2026.03.004

BibTeX
@article{Hoover2026,
  author = {Hoover, Paul J and Eisenhaure, Thomas M and Hodgin, Jeffrey and Apruzzese, William and Mears, Joseph and Peters, Michael and Jones, Tony and Shah, Sujal I and Kamal, Haniya and Leavitt, Rollin and Jackson, Shaun W and Danaher, Patrick and Rao, Deepak A and Xiao, Qian and Gurajala, Siddarth and Ai, Junting and Fava, Andrea and Berthier, Celine C and Horisberger, Alice and Barnas, Jennifer L and Izmirly, Peter M and Belmont, H Michael and Clancy, Robert and Furie, Richard and Aranow, Cynthia and Guthridge, Joel M and Dall'Era, Maria and Wofsy, David and Kamen, Diane L and Kalunian, Kenneth C and McMahon, Maureen A and Grossman, Jennifer and Payan-Schober, Fernanda and Hildeman, David A and Woodle, E Steve and Putterman, Chaim and Kretzler, Matthias and Clark, Marcus R and Raychaudhuri, Soumya and James, Judith A and Anolik, Jennifer H and Petri, Michelle A and Buyon, Jill P and Accelerating Medicines Partnership (AMP) RA/SLE Network, Accelerating Medicines Partnership (AMP) RA/SLE Network and Diamond, Betty and Davidson, Anne and Hacohen, Nir and Arazi, Arnon},
  title = {Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  volume = {85},
  number = {7},
  pages = {1324--1340},
  doi = {10.1016/j.ard.2026.03.004}
}
Kostenlos starten →